Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

52.2K
Overview
52.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Particularly strong immune response to influenza vaccination in patients with decompensated liver cirrhosis linked to systemic inflammation.

Frontiers in immunology·2026
Same author

Interferon-related inflammaging links epigenetic age acceleration to multimorbidity.

Cell genomics·2026
Same author

Health-related quality-of-life associated with Chagas disease in Argentina and Spain.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

A Viral Neuraminidase-Specific Sensor for Taste-Based Detection of Influenza.

ACS central science·2025
Same author

Evaluation of 1<sup>st</sup> WHO anti-malaria reference reagent for competition ELISA harmonisation and development of ADAMSEL analytical platform.

Biologicals : journal of the International Association of Biological Standardization·2025
Same author

Sex-specific DNA methylation associations with circulating urate levels and BCG-induced urate changes.

Communications medicine·2025

Related Experiment Video

Updated: Feb 24, 2026

Influenza A Virus Studies in a Mouse Model of Infection
10:44

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

30.0K

Roads to advanced vaccines: influenza case study.

Peggy Riese1, Carlos A Guzmán1

  • 1Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, D-38124, Braunschweig, Germany.

Microbial Biotechnology
|August 16, 2017
PubMed
Summary

Microbial biotechnology advances vaccine development for diseases lacking effective vaccines. This approach improves and creates new strategies for better vaccines, exemplified by influenza vaccine innovation.

More Related Videos

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

13.3K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.7K

Related Experiment Videos

Last Updated: Feb 24, 2026

Influenza A Virus Studies in a Mouse Model of Infection
10:44

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

30.0K
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

13.3K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.7K

Area of Science:

  • Vaccinology
  • Microbial Biotechnology
  • Infectious Disease Prevention

Background:

  • Vaccines are crucial for public health, yet challenges exist for diseases with unavailable or ineffective vaccines.
  • Existing vaccines may require periodic adaptation to remain effective against evolving pathogens.

Purpose of the Study:

  • To explore how advances in microbial biotechnology can overcome current vaccine development roadblocks.
  • To illustrate the potential of biotechnology in creating improved vaccine approaches using influenza as a case study.

Main Methods:

  • Review of current vaccine development limitations.
  • Analysis of microbial biotechnology applications in vaccinology.
  • Case study focusing on influenza vaccine advancements.

Main Results:

  • Biotechnology offers novel platforms for vaccine design and production.
  • Potential for enhanced immunogenicity and broader protective capacity of new vaccines.
  • Improved strategies for rapid vaccine adaptation to emerging strains.

Conclusions:

  • Microbial biotechnology is pivotal for developing next-generation vaccines.
  • This field provides solutions for diseases with unmet vaccine needs.
  • Advancements promise more effective and adaptable vaccines for global health security.